Fetal and neonatal liver tumours

Early Human Development

Volumn 86, Issue 10, 2010, Pages 637-642

  Makin, Erica ^a   Davenport, Mark ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Haemangioendotheliomas; Hepatic haemangiomas; Hepatoblastoma; Mesenchymal hamartoma; Vascular lesions

Indexed keywords

ALPHA FETOPROTEIN; ALPHA INTERFERON; CARBOPLATIN; CATECHOLAMINE; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIGOXIN; DIURETIC AGENT; DOXORUBICIN; HYDROCORTISONE; PROPRANOLOL; VINCRISTINE;

ABDOMINAL DISTENSION; ARTICLE; ARTIFICIAL EMBOLISM; ASPIRATION; BLEEDING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CATECHOLAMINE URINE LEVEL; CHORIOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DISSEMINATED INTRAVASCULAR CLOTTING; ECHOGRAPHY; EMBRYOLOGY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FETAL TUMOR; FETUS; FETUS HYDROPS; HAMARTOMA; HEART FAILURE; HEMANGIOENDOTHELIOMA; HEPATIC ARTERY; HEPATIC ARTERY LIGATION; HEPATOBLASTOMA; HEPATOMEGALY; HUMAN; HYDRAMNIOS; LIVER HEMANGIOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; MATERNAL DISEASE; MATERNAL MIRROR SYNDROME; MYELITIS; NEUROBLASTOMA; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL PERIOD; PLACENTA DISORDER; PRENATAL PERIOD; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; TERATOMA; THROMBOCYTE TRANSFUSION; VASCULAR TUMOR; WATCHFUL WAITING; YOLK SAC TUMOR;

FEMALE; FETAL DISEASES; HAMARTOMA; HEMANGIOENDOTHELIOMA; HEPATOBLASTOMA; HUMANS; INFANT, NEWBORN; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MESODERM; PRACTICE GUIDELINES AS TOPIC; ULTRASONOGRAPHY, PRENATAL; WATCHFUL WAITING;

EID: 77958461194     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.08.023     Document Type: Article

References (24)

1. Von Schweinitz D. Neonatal liver tumours. Semin Neonatol 2003, 8:403-410.
2. Isaacs H. Fetal and neonatal hepatic tumours. J Pediatr Surg 2007, 42:1797-1803.
3. Hernández F., Navarro M., Encinas J.L., López Gutiérrez J.C., et al. The role of GLUT1immunostaining in the diagnosis and classification of liver vascular tumors in children. J Pediatr Surg 2005, 40:801-804.
4. North P.E., Waner M., Mizeracki A., Mrak R.E., Nicholas R., Kincannon J. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001, 137:559-570.
5. Barnés C.M., Huang S., Kaipainen A., et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 2005, 102:19097-19102.
6. Roos J.E., Pfiffner R., Stallmacj T., et al. Infantile hemangioendothelioma. Radiographics 2003, 23:1649-1655.
7. Davenport M., Hansen L., Heaton N.D., Howard E.R. Hemangioendothelioma of the liver in infants. J Pediatr Surg 1995, 30:44-48.
8. Ayling R.M., Davenport M., Hadzic N., Metcalfe R., Buchanan C.R., Howard E.R. Mieli-Vergani G. Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. J Pediatr 2001, 138:932-935.
9. Gembruch U., Baschat A.A., Gloeckner-Hoffmann K., Gortner L., Germer U. Prenatal diagnosis and management of fetuses with liver hemangiomata. Ultrasound Obstet Gynecol 2002, 19:454-460.
10. Morris J., Abbott J., Burrows P., Levine D. Antenatal diagnosis of fetal hepatic hemangioma treated with maternal corticosteroids. Obstet Gygnecol 1999, 94:813-815.
11. Mejides A.A., Adra A.M., O'Sullivan M.J., Nicholas M.C. Prenatal diagnosis and therapy for a fetal hepatic vascular malformation. Obstet Gynecol 1995, 85:850-853.
12. Marsciani A., Pericoli R., Alaggio R., Brisigotti M., Vergine G. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer 2010, 54:176.
13. Warmann S., Bertram H., Kardorff R., Sasse M., Hausdorf G., Fuchs J. Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg 2003, 38:1177-1181.
14. Grabhorn E., Richter A., Fischer L., Krebs-Schmitt D., Ganschow R. Neonates with severe infantile hepatic hemangioendothelioma: limitations of liver transplantation. Pediatr Transplant 2009, 13:560-564.
15. Murthi G.V.S., Paterson L., Azmy A. Chromosomal translocation in mesenchymal hamartoma of liver: what is its significance?. J Pediatr Surg 2003, 38:1543-1545.
16. Barnhart D.C., Hirschl R.B., Garver K.A., et al. Conservative management of mesenchymal hamartoma of the liver. J Pediatr Surg 1997, 32:1495-1498.
17. Ramanujam T.M., Ramesh J.C., Goh D.W., et al. Malignant transformation of mesenchymal hamartoma of the liver: case report and review of the literature. J Pediatr Surg 1999, 34:1684-1686.
18. Kitano Y., Ruchelli E., Weiner S., et al. Hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta. Fetal Diagn Ther 2000, 15:134-138.
19. Cornette J., Festen S., van der Hoonaard T.L., Steegers E.A.P. Mesenchymal hamartoma of the liver: a benign tumour with deceptive prognosis in the perinatal period. Fetal Diagn Ther 2009, 25:196-202.
20. Bejvan S.M., Winter T.C., Shields L.E., et al. Prenatal evaluation of mesenchymal hamartoma of the liver: gray scale and power Doppler sonographic imaging. J Ultrasound Med 1997, 16:227-229.
21. Dehner L.P. Hepatic tumours in the pediatric age group: a distinctive clinical pathologic spectrum. Perspect Pediatr Pathol 1978, 4:217-268.
22. Doss B.J., Vicari J., Jacques S.M., Qureshi F. Placental involvement in congenital hepatoblastoma. Pediatr Dev Pathol 1998, 1:538-542.
23. Roebuck D.J., Aronson D., Clapuyt P., et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by SIOPEL group. Pediatr Radiol 2007, 32:123-132.
24. Czaudema P., Otte J.B., Aronson D.C., et al. Guidelines for surgical treatment of hepatoblastoma in the modern era-recommendations from the childhood liver tumour strategy group of the international society of paediatric oncology (SIOPEL). Eur J Cancer 2005, 41:1031-1036.